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1. Introduction
  Marine organisms have been used for medical purposes in 
India, China, the nearest and Europe, since ancient time. 
In the recent past, several pharmacological substances of 
marine origin have been developed. The discovery of the 
antibiotic activity of Penicillium notatum (P. notatum) 
by Fleming in 1929 has revolutionized medical science 
loading to the invention of the wonder drug “Penicillin”. 
The “cepholothin” (marketed as ‘Keflin’ by Lilly 
pharmaceutical co. USA; Osol et al 1967) is an antibiotic, 
active against number of penicillin resistant bacteria. 
The term drug need not be limited to its strictly medical 
usage, but should be synonymous with the term “bioactive 
compounds” as it also denotes any chemical substance that 
a specific physiological function.
  The wealth of antibiotics that have been isolated from 
terrestrial organisms is in extreme contrast to the poverty 
of drugs that have been obtained from marine source. 
Bioactive substances from marine mollusks gained 
prominence in recent years. The mollusks constitute the 
largest group of biotoxic marine invertebrates, widely 
distributed throughout the world. In gastropods, several 
species viz, Haliospecies rufescens (H. rufescens), Australian 
dorid nudibranches, have shown to have high antimicrobial 
activity. Among mollusks, the cephalopods have largely 
been neglected for their biomedical research. Some of the 
mollusks are believed to cure certain diseases like asthma 
and rickets. Some marine mollusks have shown pronounced 
activities, useful in the biomedical arena. The potential of 
marine mollusks as a source of biologically active products 
is largely unexplored in India[1]. Hence, a broad based 
screening of marine mollusks for bioactive compounds is 
necessary.
Objective: To search for new bioactive compounds from marine mollusks Melo melo (M. melo). 
Methods: Preliminary work for bioactive compound was identified by using disc diffusion 
methods against human pathogens. Further analyses of compound were done by using TLC, 
SDS-PAGE. And also estimate the amount of protein in the samples by following Biuret 
method. Results: In antibacterial activity the maximum diameter of 24 mm zone of inhibition 
was recorded against Klebsiella pneumoniae (K. pneumoniae) strain of the mucus extract and 
minimum zone of inhibition of 11 mm was observed in Salmonella typhi (S. typhi) strain of 
body tissue extract. The antifungal activity of the extraction shows maximum activity against 
Trichophyton mentagarophytes (T. mentagarophytes) (14 mm) and minimum activity was recorded 
in Aspergillus flavus (A. flavus) (11 mm). The extract of mucus, nerve tissue, body tissue and 
kidney that showed antimicrobial activity was subjected to TLC to determine the presence of the 
peptides and amide groups, and also subjected to SDS-PAGE to estimate the molecular weight of 
proteins in a clear band were detected in the gel that represented kidney, body tissue, brain and 
mucus represent 14, 17, 22, 45 kDa. Conclusions: The extracts from marine mollusks M. melo is 
the potential source of producing bioactive compounds against human pathogens and can be used 
for synthesis of new drugs.
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2. Materials and methods
2.1. Collection and identification
  Mollusks was collected from the Pazhayaar landing center 
(Lat 11°21’32.27” N; long 79°49’24.92” E) (Figure 1). Melo 
melo (M. melo) were identified based on the taxonomical 
features (Lightfoot, 1786). The sample M. melo was washed 
extensively with water upon collection as were dissected the 
different target organ (i.e., nerves tissue, mucus, body tissue 
and kidney). The samples were transfer to 100% methanol. 
Collected organs were stored at -20 曟 before extraction.
Figure 1. Location of the sampling site.
2.2. Extraction
  The collected specimens’ organs were homogenized by 
crushing the tissue in mortar and pestle. The samples 
were extracted with methanol and than partitioned with 
chloroform.
2.3. Anti-microbial activity
2.3.1. Microbial strain used
  Antibacterial activity of mucus, nerves tissue, body tissue 
and kidney extract of Mollusks was screened against 
10 different bacterial strains Staphylococcus aureus (S. 
aureus), Salmonella typhi (Salmonella typhi), Salmonella 
paratyphi (S. paratyphi), Klebsiella oxytoca (K. oxytoca), 
Pseudomonas aeruginosa (P. aeruginosa), Escherichia coli 
(E. coli), Proteus mirabilis (P. mirabilis), Vibrio cholera 
(V. cholera), V. parahemolyticus, Klebsilla pneumonia (K. 
pneumonia) and ten fungal strains Aspergillus niger (A. 
niger), Aspergillus flavus (A. flavus), Alternaria alternaria (A. 
alternaria), Candida albicans (C. albicans), Epidermophyton 
floccossum (E. floccossum), Trichophyton mentagrophytes 
(T. mentagrophytes), Trichophyton rubrum (T. rubrum), 
Pencillium sp, Rhizopus sp, Mucor sp.
  These pathogen strains were obtained from the Department 
of Medical Microbiology (Raja Muthiah Medical College 
hospital) Annamalai University, Annamalai Nagar.
2.3.2 Anti-microbial assay of crude extract
  In vitro anti-microbial assay was carried out by disc 
diffusion method.
2.4. Thin-layer chromatography (TLC)
  As the soluble fractions showed ninhydrin positive spots 
they were subjected to purification by gel permeation 
chromatography sephadex LH 20 using methanol as eluent 
and monitored by TLC. Diagnostic thin layer chromatography 
was performed on methanol and chloroform extracts. 
They were also spotted and plates developed in varying 
proportions. Detection was done with specific color reagent 
ninhydrin, for detecting the compounds.
2.5. Estimation of protein
  Mucus, nerve tissue, body tissue and kidney were collected 
from M. melo with a fine sterile scissor. The amount of 
protein was measured by spectrometry according to the 
method of following using a calibration curve prepared with 
different concentration of (0.1-0.5 mg/mL) of bovine serum 
albumin (BSA) as standard. Biuret reagent was used as a 
color reactant and concentration was calculated in response 
to absorbance at 540 nm in spectrophotometer (spectro UK-
VIS RS).
2.6. Determination of molecular weight by using SDS-PAGE
  SDS-PAGE was performed in 12% separating gels, 
according to the method described by Laemmli (1970). The 
reference proteins for molecular weight estimation were 
different molecular weight marker proteins, which were 
used in alpha actinin (97 kDa), alpha internexin (66 kDa), 
podoplanin (43 kDa), calretinin (29 kDa), CDK6 inhibiting 
protein (18 kDa), ubiquitin conjugating enzyme (E2) (14 
kDa). The electrophoresis was carried out at constant 100 V 
for 3 h. Following electrophoresis, the protein bands were 
visualized by staining with Coomassie Brilliant-250.
3. Results
3.1. Antimicrobial assay
  Antibacterial activity of mucus, nerves tissue, and 
body tissue and kidney extract of M. melo was evaluated 
comparing to the positive control tetracycline (C). The 
zone of inhibition in different bacterial strains against 
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M. melo organs is shown in Figure 2. Among the various 
strains maximum diameter of (24 mm) zone of inhibition 
was recorded in K. pneumoniae against mucus sample and 
lowest zone of inhibition of (11 mm) was observed in V. 
parahemolyticus and S.typhi strain against nerve tissue and 
body tissue samples respectively. Among the tested ten 
pathogenic strains V. cholerae , P. aeruginosa, E. coli and 
K. oxytoca shows negative activity and rest of them shown 
positive activity.
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Figure 2. Antibacterial activity of M. melo against bacterial strain.
  The antibacterial agent of tetracycline showed activity 
against all the tested bacterial strains. Maximum activity 
against P. aeruginosa was 25 mm and the minimum activity 
was observed against P. mirablis (16 mm).
  Antifungal activity of the different organs of M. melo was 
used for the present study. The positive control agents 
fluconazole (C) showed activity against all the fungal strains 
tested. The maximum activity against A. niger was 17 mm 
and the minimum activity was observed against C. albicans 
(14 mm). Concerning the antifungal activity of the different 
organs of M. melo the maximum zone was observed against 
T. mentagarophytes strain against mucus sample and the 
minimum inhibition zone was observed in A. flavus strain 
against body tissue sample. Among the ten pathogenic 
strains C. albicans, Mucor sp, Rhizopus, E. floccosum, T. 
rubrum shows negative activity Figure 3.
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Figure 3. Antifungal activity of M. melo against fungal strains.
        
3.2. Thin layer chromatography
  TLC profiling was done for the samples of nerves tissue 
and mucus extract in solvent system of butanol, acetic acid 
and water (B:A:W) in proportions of 5:1:4. The plates when 
developed in the solvent systems showed light pink spots in 
the case of nerves tissue and mucus extract, when the TLC 
plate was sprayed with ninhydrin. The plate with fractions 
developed in BAW as the solvent system and sprayed with 
ninhydrin, showing pink spots indicating the presence of 
amino acids and peptides is shown in Figure 4.
Figure 4. Thin layer chromatography.
3.3. Estimation of protein
  Extracted samples were centrifuged and a supernatant 
part is aspirated through micropipette. 0.5 mL separated 
supernatant part is subjected to protein quantification by 
Biuret method. The amount of protein present in the mucus 
extract is 11.6%, body tissue 15.8%, kidney 0.5% and the 
nerves tissues extract contains 12.3%.
3.4. Determination of molecular weight by using SDS-PAGE
  The M. melo samples showed antibacterial activity was 
subjected to SDS-PAGE to estimate the molecular weight 
of proteins present in it. Different standard were used to 
determine the molecular weight of sample proteins. The 
stained gel revealed that the sample contained a simple 
population of proteins. They are different molecular 
weight marker proteins used in alpha actinin (97 kDa), 
alpha internexin (66 kDa), podoplanin (43 kDa), calretinin 
(29 kDa), CDK6 inhibiting protein (18 kDa), ubiquitin 
conjugating enzyme (E2) (14 kDa). The clear bands are 
detected in the gel of kidney, body tissue, nerve tissue and 
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mucus represent 14, 17, 22, 45 kDa is shown in Figure 5. 
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Figure 5. SDS PAGE Lane. 
M: Molecular weight marker proteins.
Alpha actinin (97 kDa), alpha internexin (66 kDa), podoplanin (43 
kDa), calretinin (29 kDa), CDK6 inhibiting protein (18 kDa), ubiquitin 
conjugating enzyme (E2) (14 kDa).
4. Discussion
  In the present investigation a prominent antimicrobial 
activity has been observed against some bacterial strains. 
The methanol extraction of M. melo shows activity against 
both bacterial and fungal strains. In antibacterial activity 
the maximum diameter of zone of inhibition was recorded in 
K. pneumoniae strain and minimum zone of inhibition was 
observed in S. typhi strain. The antifungal activity of the M. 
melo against the fungal strains the maximum activity was 
showed against T. mentagarophytes and minimum activity 
showed against A. niger. The study of bioactive compound 
of coral associated gastropod, Trochus tentorium against the 
human pathogens has shown the similar result[1]. Dolastatins 
are a group of cyclic and linear peptides isolated from the 
marine mollusk Dolabella auricularia, with prominent cell 
growth suppressing activity. From mollusks it has been 
also isolated another prominent family of peptides, in this 
case highly compact and stable linear peptides, known as 
conotoxins but with specific actions on ion channels and 
membrane receptors of excitable cells[2]. The antimicrobial 
activity of gill extraction of Perna viridis was observed 
maximum against S. aureus, P. mirabilis, K. pneumonia and 
K. oxytoca[3]. This study corroborates the results of present 
investigation. Very similar to this pronounced inhibition was 
conferred by the acetone extracts of D. margariticola against 
dreadful human bacterial pathogens[4].
  The presence of antibacterial compound in the oyster 
Pteria chinensis, crab Portunus sanguinolentus and bivalve 
Perna viridis has been reported using the various solvent 
extracts[5, 10], the recombinant abalone lysozyme of Haliotis 
discus hannai was determined by using turbidimetric 
assays[6]. Bursatellanin-P, a 60 kDa protein was purified 
from the purple ink of the sea hare Bursatella leachii. The 
protein exhibited anti-HIV activity. The first total syntheses 
of aplyolides B-E, ichthyotoxic macrolides isolated from 
the skin of sea hare Aplysia depilans, have been reported 
confirming the absolute stereochemistry reported for the 
metabolites[7]. A saccharothrixmicine were isolated from the 
actinomycete Saccharothrix espanaensis An 113 associated 
with the marine mollusk Anadara broughtoni  containing 
fraction exhibited activity towards C. albicans and 
Xanthomonas sp. pv. badrii where as the diketopiperazines 
showed antibiotic activities against V. alginolyticus and V. 
parahaemolyticus[8].Marine mollusk antimicrobial peptides, 
specifically those isolated from mussels, scallops, oysters, 
venerid clams and abalone, which mainly include MGD, 
mytilin, myticin, mytimycin, big defensin, and RPD-1. 
Their structural characteristics, antibacterial activity, and 
expression pattern as well as peptide distribution and their 
release following microbial challenge[9].
  It was found, that mollusk specimens are colonized by a 
community of diverse cultivable microorganisms, which 
may supply their host bivalve with bioactive metabolites 
providing vital functions or chemical protection from 
colonization by opportunistic microorganisms. The study 
of marine mollusc-associated bacteria is of importance for 
our understanding of their ecological role in the interaction 
with animals and between themselves, and also for their 
biotechnological application as producers of bioactive 
compounds[11]. The polysaccharides have been extracted 
from the cuttlebone of S. aculeata and S. brevimana showed 
promising antibacterial and antifungal activity against the 
human pathogenic strains[12,13]. Two antimicrobial peptides, 
defensins A and B, Mytilins A and B, Mytimycin Myticin 
A and B display antibacterial activity against gram-
positive bacteria, and myticin B is active against the fungus 
Fusarium oxysporum and gram-negative bacteria E. coli 
D31 from Mytilus edulis and Mytilus galloprovincialis. In 
addition this, antibacterial activity has been measured in 
unfractionated plasma from the mussel Geukensia demissa 
and from the oyster Crassostrea virginica[14]. In the present 
study methanol extract of mucus, nerve tissue, body tissue 
and kidney that showed antimicrobial activity was subjected 
to TLC to determine the presence of the peptides and amide 
groups and also subjected to SDS-PAGE to estimate the 
number and molecular weight of proteins present. After 
electrophoresis the clear band were detected in the gel 
which represented proteins of molecular weight of kidney, 
body tissue, brain and mucus represent 14, 17, 22, 45 kDa. 
From the present study the marine mollusks M. melo have 
the potential of antimicrobial substance and also used for 
synthesis of the new drugs formulation.
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